Raloxifene promotes adipocyte differentiation of 3T3-L1 cells

European Journal of Pharmacology

Volumn 538, Issue 1-3, 2006, Pages 1-4

  Murase, Yuko ^a   Kobayashi, Junji ^a   Nohara, Atsushi ^a   Asano, Akimichi ^a   Yamaaki, Naoto ^a   Suzuki, Kaoru ^c   Sato, Hiroshi ^b   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Sapporo Medical University   (Japan)

^c NONE

Author keywords

3T3 L1 adipocyte; Adiponectin; Lipoprotein lipase; Raloxifene

Indexed keywords

ADIPONECTIN; ESTRADIOL; FATTY ACID BINDING PROTEIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RALOXIFENE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; GENE TARGETING; LIPID STORAGE; LIPOGENESIS; METABOLIC SYNDROME X; MOUSE; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; ESTRADIOL; ESTROGEN ANTAGONISTS; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION; LIPIDS; LIPOPROTEIN LIPASE; MICE; RALOXIFENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33646507069     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.033     Document Type: Article

References (14)

1. Combs T.P., Wagner J.A., Berger J., Doebber T., Wang W.J., Zhang B.B., Tanen M., Berg A.H., O'Rahilly S., Savage D.B., Chatterjee K., Weiss S., Larson P.J., Gottesdiener K.M., Gertz B.J., Charron M.J., Scherer P.E., and Moller D.E. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143 (2002) 998-1007
2. Dieudonne M.N., Leneveu M.C., Giudicelli Y., and Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am. J. Physiol., Cell Physiol. 286 (2004) C655-C661
3. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., and Mantzoros C.S. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J. Clin. Endocrinol. Metab. 88 (2003) 4823-4831
4. Green H., and Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5 (1975) 19-27
5. Green H., and Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7 (1976) 105-113
6. Grese T.A., Cho S., Finley D.R., Godfrey A.G., Jones C.D., Lugar III C.W., Martin M.J., Matsumoto K., Pennington L.D., Winter M.A., Adrian M.D., Cole H.W., Magee D.E., Phillips D.L., Rowley E.R., Short L.L., Glasebrook A.L., and Bryant H.U. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. J. Med. Chem. 40 (1997) 146-167
7. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., and Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J. Biol. Chem. 275 (2000) 11404-11411
8. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
9. Palin S.L., McTernan P.G., Anderson L.A., Sturdee D.W., Barnett A.H., and Kumar S. 17Beta-estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism 52 (2003) 383-388
10. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., and Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 68 (2004) 975-981
11. Salmenniemi U., Ruotsalainen E., Pihlajamaki J., Vauhkonen I., Kainulainen S., Punnonen K., Vanninen E., and Laakso M. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 (2004) 3842-3848
12. Somjen D., Tordjman K., Waisman A., Mor G., Amir-Zaltsman Y., Kohen F., and Kaye A.M. Estrogen stimulation of creatine kinase B specific activity in 3T3L1 adipocytes after their differentiation in culture: dependence on estrogen receptor. J. Steroid Biochem. Mol. Biol. 62 (1997) 401-408
13. Tanko L.B., Bruun J.M., Alexandersen P., Bagger Y.Z., Richelsen B., Christiansen C., and Larsen P.J. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 110 (2004) 2246-2252
14. Wang X., and Kilgore M.W. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol. Cell. Endocrinol. 194 (2002) 123-133